Page 100 - 83_01

Alain Li-Wan-Po

32. Li-Wan-Po A, Farndon P, Cooley C, Lithgow J. When
Is a Genetic Test Suitable for Prime Time? Predicting
the Risk of Prostate Cancer as a Case-Example. Public
Health Genomics 2009;13:55-62.

33. Takahashi K, Yamanaka S. Induction of pluripotent
stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell 2006;126:663-76.

34. Shi Y, Inoue H, Wu JC, Yamanaka S. Induced
pluripotent stem cell technology: a decade of progress.
Nat Rev Drug Discov 2016.

35. Udpa N, Million RP. Monoclonal antibody
biosimilars. Nat Rev Drug Discov 2016;15:13-4.

36. Lin H, Ouyang H, Zhu J, et al. Lens regeneration
using endogenous stem cells with gain of visual
function. Nature 2016;531:323-8.

37. Lin H, Ouyang H, Zhu J, et al. Corrigendum: Lens
regeneration using endogenous stem cells with gain of
visual function. Nature 2016.

38. Millis JS. Pharmacists for the future. The report of the
study commission on pharmacy Ann Arbor: The
American Association of Colleges of Pharmacy; 1975.

39. Ehrlich P. On immunity with special reference to the
cell life. In: Himmelweit F, ed. The collected papers
of Paul Ehrlich. London: Pergamon Press; 1900:178-
95.

40. Ehrlich P. Closing notes on the experimental
chemotherapy of Spirilloses. In: Die experimentelle
Chemotherapie der Spirillosen. Ehrlich P, Hata S.
Springer Berlin 1910. In: Himmelweit F, Marquardt
M, Dale H, eds. The collected papers of Paul Ehrlich
1960. London: Pergammon Press; 1910:282-309.

41. Li-Wan-Po A. Genomic Medicine 101 Keynotes and
Concepts. Nottingham: Centre for Evidence-Based
Practice; 2014.

100 @Real Academia Nacional de Farmacia. Spain